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Introduction
HMGB1, an evolutionarily ancient and abundant DNA-
binding protein within the nucleus, acts as a Damage
Associated Molecular Pattern (DAMP) molecule extracel-
lularly to promote immunity. During both cellular stress
and immune cell activation, it is translocated into the cyto-
sol and enhances autophagic flux. DCs are critical to both
initiating and maintaining T cell adaptive immunity in
human cancers. As such, they have formed the basis of
many anti-tumor immunotherapies aimed at directing
responses to tumor-associated antigens. Vaccinia virus, a
large, enveloped virus with dsDNA genome, can infect
DCs and inhibit DC maturation. HMGB1 is required for
DC functionality and chemotaxis but how HMGB1 regu-
lates DC function in anti-tumor immune response and
viral clearance remains unclear.
Methods
Mice with HMGB1 specifically knocked-out in DCs
(DCH) were generated by crossing HMGB1 floxed mice
with CD11c Cre mice. For subcutaneous tumor model,
wide type (WT), flox/flox and DCH mice were inoculated
with 5x105 Panc02 murine pancreatic cancer cells and
5x105 MC38 murine colorectal cancer cells. For the bone
marrow (BM) transplant model, 8 week old Pdx1-Cre:
KrasG12D/+(KC mice) were reconstituted via tail vain
injection of 1x106 freshly isolated BM cells from either
DCH or WT after BM progenitor depletion via 1000rad
gamma-irradiation. For the virus model, WT and DCH
mice were injected with 1x107 luc+ vaccinia virus.
Results
While tumors readily grew in both WT and flox/flox
mice, the growth was significantly suppressed in DCH
mice following Panc02 cancer cell challenge (p < 0.05).
The similar inhibitory function was observed in the
intrahepatic MC38 tumor model (p < 0.05). In BM
transplant experiments, WT to KC chimeras showed
both neoplastic ducts and extensive fibrogenesis. KC
mice which had received DCH bone marrow exhibited
near normal ductal morphology and a significantly
diminished occurrence of both low and high grade
PanIN lesions (p < 0.05) with reduced levels of myeloid-
derived suppressor cells (MDSCs), as well as decreased
levels of nominal regulatory T cells (Tregs) in spleen and
lower levels of infiltrating cells in pancreas (p < 0.05).
Although both WT and DCH mice cleared virus by day
7 following vaccinia virus injection, DCH mice displayed
less virus replication and faster viral clearance (p < 0.05).
This is associated with increased T cells (p < 0.01) and
CD11c+ cells (p < 0.05) within the spleen.
Conclusion
DC-specific HMGB1 knockout mice not only suppress
carcinogenesis and tumor growth but also clear vaccinia
viral infection more effectively. This has profound implica-
tions for understanding and targeting DCs and HMGB1
for therapy.
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